News
Mumbai: Haffkine Bio-Pharmaceuticals procurement cell will be seeking explanations from two pharmaceutical firms after it came to light that medicines.
Vildagliptin was generally shown to have a beneficial or neutral effect on lipid parameters; however, one study reported a small decrease in HDL cholesterol levels, ...
If vildagliptin is approved for marketing, it will add to the available treatment options for diabetes and will provide patients and health care providers with another noninjectable therapy option.
The firm already markets recently-approved Entresto (sacubitril+valsartan) to treat heart failure, and diabetes drug Galvus (vildagliptin) through its cardio-metabolic division, and is looking to ...
The patient had been diagnosed with a presumed type 2 diabetes eight years earlier treated with vildagliptin 50 mg × 2, metformin 1 000 mg × 2, glimepiride 2 mg × 1 and dapagliflozin 10 mg × 1 (for ...
Early-onset type 2 diabetes (defined as type 2 diabetes diagnosed in people aged <40 years) is an increasingly prevalent condition with a more aggressive disease trajectory than late-onset type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results